New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19 (2022)
- Authors:
- Autor USP: PERON, JEAN PIERRE SCHATZMANN - ICB
- Unidade: ICB
- DOI: 10.1016/j.msard.2021.103321
- Subjects: IMUNOLOGIA; ESCLEROSE MÚLTIPLA; DOENÇAS DO SISTEMA NERVOSO CENTRAL; NEUROMIELITE ÓPTICA; DOENÇAS DO NERVO ÓPTICO; VACINAS VIRAIS; COVID-19
- Language: Inglês
- Imprenta:
- Source:
- Título: Multiple Sclerosis and Related Disorders
- ISSN: 2211-0356
- Volume/Número/Paginação/Ano: v. 57, art. 103321, p. 1-5, 2022
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: other-oa
-
ABNT
FRAGOSO, Yara Dadalti et al. New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19. Multiple Sclerosis and Related Disorders, v. 57, p. 1-5, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.msard.2021.103321. Acesso em: 27 dez. 2025. -
APA
Fragoso, Y. D., Gomes, S., Gonçalves, M. V. M., Mendes Junior, E., Oliveira, B. E. S. de, Rocha, C. F., et al. (2022). New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19. Multiple Sclerosis and Related Disorders, 57, 1-5. doi:10.1016/j.msard.2021.103321 -
NLM
Fragoso YD, Gomes S, Gonçalves MVM, Mendes Junior E, Oliveira BES de, Rocha CF, Santos GAC dos, Tauil CB, Araujo RV, Peron JPS. New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19 [Internet]. Multiple Sclerosis and Related Disorders. 2022 ; 57 1-5.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.msard.2021.103321 -
Vancouver
Fragoso YD, Gomes S, Gonçalves MVM, Mendes Junior E, Oliveira BES de, Rocha CF, Santos GAC dos, Tauil CB, Araujo RV, Peron JPS. New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19 [Internet]. Multiple Sclerosis and Related Disorders. 2022 ; 57 1-5.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1016/j.msard.2021.103321 - O fenômeno da tolerância oral e a regulação de células patogênicas Th17 no modelo de encefalomielite experimental auto-imune
- Silencing of nuclear factor kappa b 1 gene expression inhibits colony formation, cell migration and invasion via the downregulation of interleukin 1 beta and matrix metallopeptidase 9 in renal cell carcinoma
- Imunomodulação e neuroimunologia em modelos experimentais: encefalomielite autoimune e sindrome congênita do zika vírus
- Targeting adrenergic receptors to mitigate invariant natural killer T cells-induced acute liver injury
- The effect of low-level laser irradiation on sperm motility, and integrity of the plasma membrane and acrosome in cryopreserved bovine sperm
- Endostatin gene therapy inhibits intratumoral macrophage M2 polarization
- Zika virus-associated brain damage: animal models and open issues
- Direct and indirect impact of SARS-CoV-2 on the brain
- The diterpene from Sphagneticola trilobata (L.) Pruski, kaurenoic acid, reduces lipopolysaccharide-induced peritonitis and pain in mice
- Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE
Informações sobre o DOI: 10.1016/j.msard.2021.103321 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
